Enochian Biosciences Inc (13)
Browse by Contract Category
Contracts
-
Employment Agreement between Enochian Biosciences, Inc. and Dr. Mark Dybul, dated August 11, 2021
(Filed With SEC on August 16, 2021)
-
License Agreement
(Filed With SEC on April 22, 2021)
-
Form of Subscription Agreement
(Filed With SEC on March 24, 2021)
-
Description of Securities
(Filed With SEC on September 23, 2020)
-
Purchase Agreement, dated July 8, 2020, by and between the Company and Lincoln Park Capital Fund, LLC
(Filed With SEC on July 14, 2020)
-
Registration Rights Agreement, dated July 8, 2020, by and between the Company and Lincoln Park Capital Fund, LLC
(Filed With SEC on July 14, 2020)
-
Promissory Note
(Filed With SEC on March 31, 2020)
-
Note Purchase Agreement
(Filed With SEC on March 31, 2020)
-
Enochian Biosciences, Inc. 2019 Equity Incentive Plan
(Filed With SEC on February 10, 2020)
-
License Agreement
(Filed With SEC on February 3, 2020)
-
Consulting Agreement by and between the Company and G-Tech Bio, LLC July 9, 2018
(Filed With SEC on September 30, 2019)
-
Offer Letter from the Company to Luisa Puche, dated December 28, 2018
(Filed With SEC on September 30, 2019)
-
Amended and Restated Director Agreement by and between the Company and Mark Dybul, as amended, dated May 1, 2019
(Filed With SEC on September 30, 2019)